Eagle Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,048.50
5,506.00
2,571.00
81,453.00
51,943.00
31,903
Depreciation, Depletion & Amortization
135.00
13.00
112.00
1,589.00
3,747.00
3,670
Other Funds
19.60
-
-
286.00
-
27,168
Funds from Operations
3,047.60
5,209.00
7,007.00
61,901.00
88,488.00
60,273
Changes in Working Capital
2,832.30
2,666.00
16,725.00
8,694.00
29,569.00
7,889
Net Operating Cash Flow
5,879.90
7,875.00
9,718.00
53,207.00
58,919.00
52,384
Capital Expenditures
40.50
11.00
1,881.00
20,690.00
5,186.00
Purchase/Sale of Investments
1,500.00
19,999.00
-
-
-
Net Investing Cash Flow
1,459.50
19,988.00
1,881.00
45,800.00
5,186.00
Issuance/Reduction of Debt, Net
-
-
-
-
47,558.00
Net Financing Cash Flow
9,809.10
34.00
55,813.00
33,670.00
8,104.00
Net Change in Cash
5,388.70
12,147.00
44,214.00
26,263.00
61,837.00
Free Cash Flow
5,920.40
7,886.00
11,599.00
51,617.00
54,483.00
Deferred Taxes & Investment Tax Credit
-
-
-
30,116.00
17,289.00
2,468
Net Assets from Acquisitions
-
-
-
26,860.00
-
Other Sources
-
-
-
1,750.00
-
Change in Capital Stock
9,828.70
34.00
55,813.00
33,384.00
39,454.00
About Eagle Pharmaceuticals
View Profile
